Background Though undiagnosed in many patients, especially those with cryptogenic stroke, atrial fibrillation (AF) is a key ...

Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...